BeyondSpring Inc(NASDAQ:BYSI) 
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development and commercialization of immuno-oncology cancer therapies. The company's lead asset is the Plinabulin that is in late stage clinical trials as an anti-cancer agent in combination...
Website: http://www.beyondspringpharma.com
Founded: 2010
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.50
H 1.66
L 1.34
C 1.36
V 45,054
10EMA 1.36
20EMA 1.36
60EMA 1.36
120EMA 1.36
250EMA 1.36